Novo Nordisk A/S Profit Margin

Novo Nordisk A/S's profit margin stands at 35.35% as of June 2026. That compares with 35.61% in the prior-year period — down 0.7% year over year. That is above the Healthcare sector average of 9.48%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Novo Nordisk A/S reported 35.35% in profit margin versus 35.61% a year earlier — a 0.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Novo Nordisk A/S sits higher the Healthcare benchmark (9.48%) with a profit margin of 35.35%. That is roughly 272.8% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 35.35% for Novo Nordisk A/S means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Novo Nordisk A/S's profit margin evolved across reporting periods, while the comparison chart places NOVC.DE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.